{"schema_version":"secwatch.filing_event.v1","accession":"0001193805-24-000806","form_type":"8-K","ticker":"ARCT","cik":"0001768224","company_name":"Arcturus Therapeutics Holdings Inc.","filed_at":"2024-06-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:19.976200+00:00","generated_at":"2026-06-01T04:22:43.332606+00:00","sec_items":["5.02","5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Arcturus stockholders approve 2M share increase to equity incentive plan at annual meeting","bullets":["Amendment to 2019 Omnibus Equity Incentive Plan approved: shares increased by 2,000,000 to 10,750,000 total.","All eight director nominees elected (e.g., Peter Farrell, Joseph Payne) to serve until 2025 annual meeting.","Say-on-pay approved with 19,875,930 For, 1,069,592 Against, 58,600 Abstain.","Ratification of Deloitte & Touche LLP as independent auditor for FY 2024 ratified (23,267,449 For)."],"urls":{"canonical":"https://secwatch.observer/filing/0001193805-24-000806","json":"https://secwatch.observer/filing/0001193805-24-000806.json","markdown":"https://secwatch.observer/filing/0001193805-24-000806.md","text":"https://secwatch.observer/filing/0001193805-24-000806.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1768224/000119380524000806/0001193805-24-000806-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1768224/000119380524000806/e663711_8k-arct.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T04:22:43.332606+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}